Literature DB >> 24089160

Factors related with the progression of chronic kidney disease.

Claudia Yuste, Daniel Barraca, Inés Aragoncillo-Sauco, Almudena Vega-Martínez, Soraya Abad, Úrsula Verdalles-Guzmán, Caridad Ruiz-Caro, Jara Ampuero, Juan M López-Gómez.   

Abstract

BACKGROUND: Our aims were to determine the rate of progression of chronic kidney disease (CKD) and to identify predictors, with particular emphasis on bone and mineral metabolism.
METHODS: Retrospective and observational study including 300 patients with advanced CKD (61.2% males, 33.1% diabetics; age 65.6±14 years). Mean follow-up time was 19.4±10.1 months. Baseline estimated glomerular filtration rate (eGFR) (MDRD-4) was 22.5±7.18 mL/min. To calculate the rate of decline in eGFR, we used the slope of the regression line between all determinations of eGFR and follow-up time. We calculated the mean values for proteinuria and serum phosphate, calcium, uric acid, and PTH, as well as 24-hour urinary excretion of urea nitrogen over time for each patient. Follow-up was at least 6 months and included at least 4 measurements of eGFR.
RESULTS: The mean rate of decline eGFR (-1.64 mL/min/1.73 m²/year) was inversely correlated with serum phosphate levels (4.3±2.1 mg/dL, P<.001), PTH (256.3±193.7 ng/L, p<.001) and proteinuria (0.84±1.31 g/day, P=.004) and directly correlated with mean serum calcium (P<.001) and the presence of hypertension (P<.02). However, only serum phosphate, serum PTH, and proteinuria persisted as predictors in the multivariate analysis. Stable-GFR patients (positive slope) were older (P=.041) and had lower serum phosphate and PTH levels (P<.01 and P<.01 respectively) and lower proteinuria (P<.01).
CONCLUSIONS: The rate of decrease in eGFR was correlated with serum phosphate and PTH levels and proteinuria. All of these factors can be modified with an adequate treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24089160     DOI: 10.3265/Nefrologia.pre2013.May.11900

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  4 in total

1.  Renal SGLT mRNA expression in human health and disease: a study in two cohorts.

Authors:  Vikas Srinivasan Sridhar; Jaya Prakash N Ambinathan; Matthias Kretzler; Laura L Pyle; Petter Bjornstad; Sean Eddy; David Z Cherney; Heather N Reich
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-23

2.  Haematuria increases progression of advanced proteinuric kidney disease.

Authors:  Claudia Yuste; Alfonso Rubio-Navarro; Daniel Barraca; Inés Aragoncillo; Almudena Vega; Soraya Abad; Alba Santos; Nicolás Macias; Ignacio Mahillo; Eduardo Gutiérrez; Manuel Praga; Jesús Egido; Juan Manuel López-Gómez; Juan Antonio Moreno
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

3.  Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study.

Authors:  Herbert S Chase; Jamie S Hirsch; Sumit Mohan; Maya K Rao; Jai Radhakrishnan
Journal:  BMC Nephrol       Date:  2014-11-27       Impact factor: 2.388

4.  Normal parathyroid hormone and non-proliferative diabetic retinopathy in patients with type 2 diabetes.

Authors:  Shengnan Sun; Yahao Wang; Wenru Ma; Bingfei Cheng; Bingzi Dong; Yuhang Zhao; Jianxia Hu; Yue Zhou; Yajing Huang; Fanxiang Wei; Yangang Wang
Journal:  J Diabetes Investig       Date:  2020-12-02       Impact factor: 4.232

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.